InvestorsHub Logo
Followers 20
Posts 2942
Boards Moderated 1
Alias Born 04/27/2000

Re: None

Tuesday, 10/08/2002 10:01:19 AM

Tuesday, October 08, 2002 10:01:19 AM

Post# of 110
OUTLINE of INVESTOR QUESTIONS and CONCERNS
Prepared for the September 25th, 2002 Conference call

01. Aerus - merger? Licensing agreement?
CC. Merger is off; DB working on licensing which is still possible.

02. Nova-Biogenetics, status, funding, IPO - what?
03. Anthrax - update status.
04. NALCO - last CC - TM mentioned a PR due on contract? Status of relationship with NALCO.
05. European Health approval for use in paper pulp industry.
CC. Missed filing deadline of 3/31/02 to be grandfathered; seeking other avenues for approval.

06. ePetstop 2.5 million contract? Out-of-stock?
07. AHT lawsuit - update - status with BioShield the company now that BOD is off of the hook.
08. Wm. Zinsser & Co., Inc Jan. 28, 2002 PR stated completion of a written agreement soon.
09. Cash position of company, especially with recent S-8 filing for 7 million shares.
10. China repatriate funds? Regulations pulling out funds? Is Megastar paying - Q doesn't reflect.
11. Tim Moses' duties?
12. Insider sales? On 7/11/02 Doctors K. Smith 212K and Rodothea Milatov 196K
CC. BOD members are not paid a salary, only compensation is shares. Yes they sold.

13. MCVI Did they exercise their first two sets of warrants as Avi posted he would do?
CC. Contract with MCVI has been terminated. Ammended 13-G to be filed.

14. Avi what has he done for the company with regard to his contract.
CC. See above

15. Shorting this stock from off-shore? How many shares are shorted? Take legal action, join existing suit?
16. Steve Hicks recent legal woes; relationship to BioShield, preferred shares and shorting this stock via ERNS.
17. BST 1870; products made and sold using BST 1870? Future? (deals made or in the works)? How will the company see it through to its potential?
18. Increased Sales - how does Deirdre plan to accomplish that?
19. Shares Outstanding and float. Plus an accounting of how we go from the last number 61 mil to whatever number.
20. Shares paid to consultants better breakdown in K and Q.
21. Board Member Angela B. Howell status? SEC 8-K filing to reflect Report of Unscheduled Material Event - where is it?
22. P/T CFO Adam Wasserman signature missing from recent S-8, why?
23. Reverse split? Do you have any intentions of a reverse split with in the next year?
24. Sales from last Q and bad debt.
25. J. Elfersley Status? Key employee to make the product, and 2 sales people TM mentioned in last CC.
CC. J. Elfersley is no longer with the company. Going to hire a microbiologist and a technical sales person.

26. Shareholders meeting? When and where.




The best weapon against "fear" is "facts"!!



The best weapon against "fear" is "facts"!!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.